{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:36:34Z","timestamp":1771547794385,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0001\/2013"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0001\/2013"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-OSM\/104124\/2008"],"award-info":[{"award-number":["PTDC\/SAU-OSM\/104124\/2008"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/61045\/2009"],"award-info":[{"award-number":["SFRH\/BD\/61045\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/63962\/2009"],"award-info":[{"award-number":["SFRH\/BD\/63962\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004494","name":"Nature Conservancy of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004494","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bcp.2014.06.014","type":"journal-article","created":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T12:01:32Z","timestamp":1403352092000},"page":"61-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment"],"prefix":"10.1016","volume":"91","author":[{"given":"P.C.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sereno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2014.06.014_bib0005","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0031-3955(03)00121-4","article-title":"Current immunosuppressive agents: efficacy, side effects, and utilization","volume":"50","author":"Smith","year":"2003","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bcp.2014.06.014_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1478-811X-7-25","article-title":"Novel inhibitors of the calcineurin\/NFATc hub\u2014alternatives to CsA and FK506?","volume":"7","author":"Sieber","year":"2009","journal-title":"Cell Commun Signaling: CCS"},{"issue":"1","key":"10.1016\/j.bcp.2014.06.014_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-200107150-00006","article-title":"Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation","volume":"72","author":"Sarwal","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bcp.2014.06.014_bib0020","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0092-8674(92)90643-Q","article-title":"Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kd S6 protein kinases","volume":"69","author":"Chung","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2014.06.014_bib0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1476-5381.2010.01018.x","article-title":"Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells","volume":"162","author":"\u00d8zbay","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2014.06.014_bib0030","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/lt.22386","article-title":"Metabolic syndrome: is immunosuppression to blame?","volume":"17","author":"Watt","year":"2011","journal-title":"Liver Transplant"},{"issue":"4","key":"10.1016\/j.bcp.2014.06.014_bib0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ecl.2007.07.003","article-title":"Immunosuppressive agents: effects on glucose and lipid metabolism","volume":"36","author":"Subramanian","year":"2007","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.bcp.2014.06.014_bib0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5414\/CPP42701","article-title":"Pharmacokinetics of immunosuppressants: a perspective on ethnic differences","volume":"42","author":"Dirks","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2014.06.014_bib0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/DMSO.S19027","article-title":"New onset diabetes after transplantation (NODAT): an overview","volume":"4","author":"Pham","year":"2011","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.bcp.2014.06.014_bib0050","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/gfs583","article-title":"Novel views on new-onset diabetes after transplantation: development, prevention and treatment","volume":"28","author":"Hecking","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bcp.2014.06.014_bib0055","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nm.2378","article-title":"Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner","volume":"17","author":"Pajvani","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2014.06.014_bib0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng890","article-title":"Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1","volume":"32","author":"Nakae","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.bcp.2014.06.014_bib0065","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1113\/jphysiol.2008.164202","article-title":"Acute exercise modulates the Foxo1\/PGC-1\u03b1 pathway in the liver of diet-induced obesity rats","author":"Ropelle","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/35093131","article-title":"CREB regulates hepatic gluconeogenesis through the coactivator PGC-1","volume":"413","author":"Herzig","year":"2001","journal-title":"Nature"},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2014.06.014_bib0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2362.32.s3.2.x","article-title":"Molecular insights into insulin action and secretion","volume":"32","author":"Rhodes","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.bcp.2014.06.014_bib0080","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0006-291X(02)00333-9","article-title":"Rapamycin partially prevents insulin resistance induced by chronic insulin treatment","volume":"293","author":"Berg","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2014.06.014_bib0085","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1210\/en.2004-0777","article-title":"Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes","volume":"146","author":"Tremblay","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2014.06.014_bib0090","doi-asserted-by":"crossref","first-page":"38052","DOI":"10.1074\/jbc.M106703200","article-title":"Amino acid and insulin signaling via the mTOR\/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells","volume":"276","author":"Tremblay","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.06.014_bib0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.transproceed.2013.02.009","article-title":"Effects of cyclosporine and sirolimus on insulin-stimulated glucose transport and glucose tolerance in a rat model","volume":"45","author":"Lopes","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bcp.2014.06.014_bib0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2012.01.024","article-title":"mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes","volume":"355","author":"Pereira","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.bcp.2014.06.014_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.trsl.2013.12.002","article-title":"Tacrolimus and sirolimus have distinct effects on insulin signaling in male and female rats","volume":"163","author":"Shivaswamy","year":"2013","journal-title":"Transl Res: J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.bcp.2014.06.014_bib0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2010.02.029","article-title":"Long-term cyclosporine treatment in non-transplanted rats and metabolic risk factors of vascular diseases","volume":"185","author":"B\u00f6hmer","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2014.06.014_bib0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bcp.2014.01.020","article-title":"Molecular mechanisms underlying the effects of cyclosporin A and sirolimus on glucose and lipid metabolism in liver, skeletal muscle and adipose tissue in an in vivo rat model","volume":"88","author":"Fuhrmann","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.bcp.2014.06.014_bib0120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12020-010-9332-6","article-title":"Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal Sprague-Dawley rats","volume":"37","author":"Shivaswamy","year":"2010","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.bcp.2014.06.014_bib0125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.bcp.2014.06.014_bib0130","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.bcp.2014.06.014_bib0135","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/j.1476-5381.2011.01716.x","article-title":"Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats","volume":"165","author":"Deblon","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0140","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/diab.34.6.580","article-title":"The disposal of an oral glucose load in healthy subjects. A quantitative study","volume":"34","author":"Ferrannini","year":"1985","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bcp.2014.06.014_bib0145","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/ndt\/gfl820","article-title":"The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man","volume":"22","author":"Hjelmesaeth","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bcp.2014.06.014_bib0150","first-page":"136","article-title":"Effects of panax quinquefolium on streptozotocin-induced diabetic rats: role of C-peptide, nitric oxide and oxidative stress","volume":"4","author":"Amin","year":"2011","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.bcp.2014.06.014_bib0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diabetes.53.1.250","article-title":"C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21\u201322 October 2001","volume":"53","author":"Palmer","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2014.06.014_bib0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/tx800253x","article-title":"Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function","volume":"22","author":"Klawitter","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.ajkd.2009.09.004","article-title":"Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial","volume":"55","author":"Franz","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bcp.2014.06.014_bib0170","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2337\/diab.34.12.1309","article-title":"Effects of cyclosporine on glucose tolerance in the rat","volume":"34","author":"Yale","year":"1985","journal-title":"Diabetes"},{"issue":"6076","key":"10.1016\/j.bcp.2014.06.014_bib0175","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.06.014_bib0180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3945\/jn.109.119883","article-title":"Rapamycin inhibits postprandial-mediated X-box-binding protein-1 splicing in rat liver","volume":"140","author":"Pfaffenbach","year":"2010","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2014.06.014_bib0185","first-page":"4483","article-title":"Post-prandial regulation of hepatic glucokinase and lipogenesis requires the activation of TORC1 signalling in rainbow trout (Oncorhynchus mykiss)","volume":"216","author":"Dai","year":"2013","journal-title":"J Exp Biol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0190","doi-asserted-by":"crossref","first-page":"21872","DOI":"10.1074\/jbc.M109.022749","article-title":"SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD","volume":"284","author":"Amat","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.06.014_bib0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","article-title":"PGC-1alpha: a key regulator of energy metabolism","volume":"30","author":"Liang","year":"2006","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.bcp.2014.06.014_bib0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2014.06.014_bib0205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","article-title":"Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy","volume":"8","author":"Bentzinger","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.06.014_bib0210","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2014.06.014_bib0215","doi-asserted-by":"crossref","first-page":"20808","DOI":"10.1073\/pnas.1111448109","article-title":"Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function","volume":"108","author":"Romanino","year":"2011","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.06.014_bib0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3892\/mmr.2012.1172","article-title":"Hydrodynamic-based delivery of PTP1B shRNA reduces plasma glucose levels in diabetic mice","volume":"7","author":"Vakili","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bcp.2014.06.014_bib0225","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.1074\/jbc.M413240200","article-title":"Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B\u2212\/\u2212 mice","volume":"280","author":"Haj","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.06.014_bib0230","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2337\/db08-0913","article-title":"Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress","volume":"58","author":"Delibegovic","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2014.06.014_bib0235","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jnutbio.2012.12.014","article-title":"Modulation of cellular insulin signaling and PTP1B effects by lipid metabolites in skeletal muscle cells","volume":"24","author":"Obanda","year":"2013","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.bcp.2014.06.014_bib0240","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.metabol.2014.02.004","article-title":"Short and long term in vivo effects of cyclosporine A and sirolimus on genes and proteins involved in lipid metabolism in Wistar rats","volume":"63","author":"Lopes","year":"2014","journal-title":"Metab: Clin Exp"},{"key":"10.1016\/j.bcp.2014.06.014_bib0245","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1007\/s00125-013-2992-z","article-title":"Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice","volume":"56","author":"Owen","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2014.06.014_bib0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.bjp.0706306","article-title":"Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats","volume":"146","author":"Wu","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0255","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrm3351","article-title":"Regulation of glucose transport by insulin: traffic control of GLUT4","volume":"13","author":"Leto","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI10582","article-title":"Signaling pathways in insulin action: molecular targets of insulin resistance","volume":"106","author":"Pessin","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2014.06.014_bib0265","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1128\/MCB.21.15.5050-5062.2001","article-title":"Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin","volume":"21","author":"Takano","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","article-title":"Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1","volume":"3","author":"Um","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.bcp.2014.06.014_bib0275","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s001250051501","article-title":"Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B\/Akt in adipocytes from Type II diabetic subjects","volume":"43","author":"Carvalho","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2014.06.014_bib0280","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1096\/fsb2fj000435fje","article-title":"Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport","volume":"15","author":"Carvalho","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2014.06.014_bib0285","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2014.06.014_bib0290","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/db09-1061","article-title":"Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism","volume":"59","author":"Kumar","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2014.06.014_bib0295","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1096\/fj.02-0367com","article-title":"Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1","volume":"16","author":"Baar","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2014.06.014_bib0300","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1073\/pnas.061035098","article-title":"Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1","volume":"98","author":"Michael","year":"2001","journal-title":"Proc Nat Acad Sci USA."},{"key":"10.1016\/j.bcp.2014.06.014_bib0305","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ncb1101-1014","article-title":"Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo","volume":"3","author":"Bodine","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bcp.2014.06.014_bib0310","doi-asserted-by":"crossref","first-page":"48794","DOI":"10.1074\/jbc.M313897200","article-title":"Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae","volume":"279","author":"Lungu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.06.014_bib0315","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1681\/ASN.2006030196","article-title":"Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?","volume":"17","author":"Di Paolo","year":"2006","journal-title":"J Am Soc Nephrol: JASN"},{"key":"10.1016\/j.bcp.2014.06.014_bib0320","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.06.014_bib0325","doi-asserted-by":"crossref","first-page":"34389","DOI":"10.1074\/jbc.C500230200","article-title":"Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes","volume":"280","author":"Danielsson","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2014.06.014_bib0330","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1172\/JCI25151","article-title":"Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents","volume":"115","author":"Morino","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214003578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214003578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:03:03Z","timestamp":1762095783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214003578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0006295214003578"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.06.014","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine A enhances gluconeogenesis while sirolimus impairs insulin signaling in peripheral tissues after 3 weeks of treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}